Synthesis, characterisation and biocompatibility of surface-functionalised gold nanoparticles

Journal of Experimental Nanoscience

Volumn 7, Issue 2, 2012, Pages 174-188

  Raji, V ^a   Kumar, Jatish ^b   Rejiya, C S ^a   Vibin, M ^a   John, Annie ^c   Abraham, Annie ^a  

^a UNIVERSITY OF KERALA   (India)

^b REGIONAL RESEARCH LABORATORY CSIR   (India)

^c SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

biodistribution; cytotoxicity; gold nanoparticle; histopathology; surface plasmon resonance

Indexed keywords

BIODISTRIBUTIONS; BIOLOGICAL APPLICATIONS; EXPERIMENTAL MODELS; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HISTOPATHOLOGY; IN-VITRO; INDUCTIVELY-COUPLED; LIVING CELL; LOCALISATION; METABOLIC CHANGES; MORPHOLOGICAL CHANGES; NANOSIZED MATERIALS; PERITONEAL CELLS; PLASMA-ATOMIC EMISSION; THERAPEUTIC APPLICATION; TISSUE DISTRIBUTIONS;

BIOCOMPATIBILITY; CELL DEATH; DIAGNOSIS; GLYCOLS; INDUCTIVELY COUPLED PLASMA; MAMMALS; METAL NANOPARTICLES; NANOCONJUGATES; SURFACE PLASMON RESONANCE; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

CYTOTOXICITY;

GOLD NANOPARTICLE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASCITES; ATOMIC EMISSION SPECTROMETRY; BIOCOMPATIBILITY; CELL STRUCTURE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EHRLICH ASCITES TUMOR; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MOUSE; NANOFABRICATION; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84864395010     PISSN: 17458080     EISSN: 17458099     Source Type: Journal    
DOI: 10.1080/17458080.2010.514952     Document Type: Article

References (45)

1. Mirkin, CA and Taton, TA. 2000. Semiconductors meet biology. Nature, 405: 626-627.
2. Sastry, M, Lala, N, Patil, V, Chavan, SP and Chittiboyina, AG. 1998. Optical absorption study of the biotin-avidin interaction on colloidal silver and gold particles. Langmuir, 14: 4138-4142.
3. Fitzmaurice, D and Connolly, S. 1999. Programmed assembly of gold nanocrystals in aqueous solution. Adv. Mater., 11: 1202-1205.
4. Mann, S, Shenton, W, Li, M, Connolly, S and Fitzmaurice, D. 2000. Biologically programmed nanoparticle assembly. Adv. Mater., 12: 147-150.
5. Sokolov, K, Follen, M, Aron, J, Pavlova, I, Malpic, A, Lotan, R and Richartz-Kortum, R. 2003. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res., 63: 1999-2004.
6. 0-PAMAM) gold dendrimer nanocomposites in cells. J. Nanopart. Res., 4: 395-403.
7. Haas, U, Thalacker, C, Adams, J, Fuhrmann, J, Riethmuller, S, Beginn, U, Ziener, U, Moller, M, Dobrawa, R and Wurthner, FJ. 2003. Fabrication and fluorescence properties of perylene bisimide dye aggregates bound to gold surfaces and nanopatterns. J. Mater. Chem., 13: 767-772.
8. Patrick O'Neal, D, Leon, RH, Naomi, JH, Donald Payne, J and West, LJ. 2004. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett., 209: 171-176.
9. Choi, M-R, Stanton-Maxey, KJ, Stanley, JK, Levin, CS, Bardhan, R, Akin, D, Badve, S, Sturgis, J, Paul Robinson, J, Bashir, R, Halas, NJ and Clare, SE. 2007. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett., 7: 3759-3765.
10. Loo, C, Alex, L, Leon, H, Min-Ho, L, Jennifer, B, Naomi, H, Jennifer, W and Rebekah, D. 2004. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat., 3: 33-40.
11. Daniel, MC and Astruc, D. 2004. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties and applications toward biology, catalysis, and nanotechnology. Chem. Rev., 104: 293-346.
12. Santosh, A, Remant, BKC, Dharmaraj, N, Narayan, B, Chi, HK and yong Kim, Hak. 2006. Spectroscopic identification of S-Au interaction in cysteine capped gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc., 63: 160-163.
13. Wuelfing, WP, Gross, SM, Miles, DT and Murray, RW. 1998. Nanometer gold clusters protected by surface-bound monolayers of thiolated poly (ethylene glycol) polymer electrolyte. J. Am. Chem. Soc., 120: 12696-12697.
14. Otsuka, H, Akiyama, Y, Nagasaki, Y and Kataoka, K. 2001. Quantitative and reversibile lectin induced association of gold nanoparticles modified with a Lactosyl-W-mercapto poly ethylene glycol. J. Am. Chem. Soc., 123: 8226-8230.
15. Bhattacharya, S and Srivastava, A. 2003. Synthesis and characterization of novel cationic lipid and cholesterol-coated gold nanoparticles and their interactions with dipalmitoylphosphatidylcholine membranes. Langmuir, 19: 4439-4447.
16. Peetla, C and Labhasetwar, V. 2009. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir, 25: 2369-2377.
17. Adams, ML, Lavasanifar, A and Kwon, GSJ. 2003. Amphiphilic block copolymers for drug delivery. Pharm. Sci., 92: 1343-1355.
18. Yang, ST, Fernando, KAS, Liu, JH, Wang, J, Sun, HF, Liu, YF, Chen, M, Huang, YP, Wang, X, Wang, HF and Sun, YP. 2008. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small, 7: 940-944.
19. Xiaoming Sun, ZL, Welsher, K, Robinson, JT, Goodwin, A, Zaric, S and Dai, AH. 2008. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res., 1: 203-212.
20. Liu, Z, Davis, C, Cai, WB, He, L, Chen, XY and Dai, HJ. 2008. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. USA., 105: 1410-1415.
21. Cheng, Y, Samia, AC, Meyers, JD, Panagopoulos, I, Fei, BW and Burda, CJ. 2008. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. Am. Chem. Soc., 130: 10643-10647.
22. Bazile, D, Prud'Homme, C, Bassoullet, MT, Marlard, M, Spenlehauer, G and Veillard, M. 1995. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci., 84: 493-498.
23. Peracchia, MT, Fattal, E, Desmaële, D, Besnard, M, Noël, JP, Gomis, JM, Appel, M, d'Anjelo, J and Couverur, P. 1999. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release, 60: 121-128.
24. Peracchia, MT, Harnisch, S, Pinto-Alphandary, H, Gulik, A, Dedieu, JC and Desmaelle, D. 1999. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials, 20: 1269-1275.
25. Li, Y, Pei, YY, Zhangb, XY, Gub, ZH, Zhoub, ZH, Yuanb, WF, Zhoub, J, Zhua, JH and Gaoa, XJ. 2001. PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J. Control. Release, 71: 203-211.
26. Gayathri Devi, D, Cibin, TR, Ramaiah, D and Abraham, A. 2008. Bis (3,5-diiodo-2,4,6-trihydroxyphenyl) squaraine: A novel candidate in photodynamic therapy for skin cancer models in vivo. J. Photobiol., 92: 153-159.
27. Zheng, M, Li, Z and Huang, X. 2004. Ethylene glycol monolayer protected nanoparticles: Synthesis, characterization and interactions with biological molecules. Langmuir, 20: 4226-4235.
28. Wilcox, WS, Griswoldd, DP, Laster, WR, Schabel, FM Jr and Skipper, HE. 1965. Experimental evaluation of potential anticancer agents. XVII, Kinetics of growth and regression after treatment of certain solid tumors. Cancer Chemother. Resp., 47: 27-39.
29. Rejiya, CS, Cibin, TR and Abraham, A. 2009. Leaves of cassia tora as a novel cancer therapeutic: An in vitro study. Toxicol. In Vitro, 23: 1034-1038.
30. Fischer, HC, Fournier-Bidoz, S, Sandy Pang, K and Warren Chan, CW. 2007. Quantitative detection of engineered nanoparticles in tissues and organs: An investigation of efficacy and linear dynamic ranges using ICP-AES. Nanobiotechnology, 3: 46-54.
31. Huang, C-C, Huang, C-W, Cheng, Y-S and Yu, J. 2008. Histamine metabolism influences blood vessel branching in zebra fish reg6 mutants. BMC Dev. Biol., 8: 31-42.
32. Reitman, S and Frankel, S. 1957. A colorimetric method for the determination of serum GOT and GPT. Am. J. Clin. Pathol., 28: 56-63.
33. Lum, G and Gambino, SR. 1974. A comparison of serum versus heparinized plasma for routine chemistry tests. Am. J. Clin. Pathol., 61: 108-113.
34. Tietz, N. 1976. Fundamentals of Clinical Chemistry, Philadelphia: W.B. Saunders.
35. Steel, RGD, Torrie, JH and Dickey, DA. 1997. Principles and Procedures of Statistics: A Biometrical Approach, New York: McGraw Hill.
36. Ipe, BI, Yoosaf, K and George Thomas, K. 2006. Functionalized gold nanoparticles as phosphorescent nanomaterials and sensors. J. Am. Chem. Soc., 6: 1907-1913.
37. Sturt, DA, Haes, AJ, Yonzon, CR, Hicks, EM and Van Duyne, RP. 2005. Biological applications of localized surface plasmonic phenominae. IEE Proc. Nanobiotechnol., 152: 13-32.
38. Griem, P and Gleichmann, EZ. 1996. Gold antirheumatic drug: Desired and adverse effects of Au (I) and Au (III) on the immune system. Rheumatology, 55: 348-358.
39. Mirabelli, CK, Johnson, RK, Sung, CM, Faucette, LF, Muirhead, K and Crooke, ST. 1985. Evaluation of the in vivo anti tumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound in murine tumor models. Cancer Res., 45: 32-39.
40. Cossu, R, Matovic, Z, Radanovic, C and Ponticelli, G. 1994. Cytotoxic activity of some gold (III) complexes. Farmaco, 49: 301-302.
41. Bhattacharya, R, Mukherjee, P, Xiong, Z, Atala, A, Soker, S and Mukhopadhyay, D. 2004. Gold nanoparticles inhibit VEGF 165- induced proliferation of HUVEC cells. Nano Lett., 4: 2479-2281.
42. Connor, EE, Mwamuka, J, Anand, G, Murphy, CJ and Wyatt, MD. 2005. Gold nanoparticles are taken up by human cells and do not cause acute cytotoxicity. Small, 1: 325-327.
43. Mohamed, KK, Shraddha, SN, Leah, DM, Muhammed, STK, Nair, BM, Wojciech, GL and Lajos, PB. 2005. In vivo biodistribution of dendrimers and dendrimer nanocomposites: Implications for cancer imaging and therapy. Technol. Cancer Res. Treat., 4: 603-613.
44. Hainfeld, JF, Slatkin, DN, Focella, TM and Smilowitz, HM. 2006. Gold nanoparticles: New X-ray contrast agent. Br. J. Radiol., 79: 248-253.
45. Allemann, E, Brasseur, N, Benrezzak, O, Rousseau, J, Kudrevich, SV, Boyle, RW, Leroux, J-C, Gurny, R and Van Lier, JE. 1995. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT -6 mouse mammary tumors. J. Pharm. Pharmacol., 47: 382-387.